|
Index of reports
> Cases with Vomiting (10)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include vomiting. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Epirubicin side effects in
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-20
Patient:
Reactions: Abdominal Pain, Vomiting, Hypersensitivity, Nausea, Skin Toxicity, Mucosal Inflammation, Fatigue, Diarrhoea, Hepatotoxicity, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Epirubicin
Indication: Breast Cancer
Fluorouracil
Indication: Breast Cancer
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Herceptin
Dosage: maintenance dose
Lapatinib
Dosage: arm b
Administration route: Oral
Indication: Breast Cancer
Lapatinib
Dosage: arm c
Administration route: Oral
Paclitaxel
Indication: Breast Cancer
Possible Epirubicin side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-23
Patient: 48 year old female
Reactions: Vomiting, Nausea, Febrile Neutropenia, Oropharyngeal Pain
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 830mg, every cycle; 800mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-27
Cyclophosphamide
Dosage: 830mg, every cycle; 800mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-06
End date: 2010-10-06
Epirubicin
Dosage: 166mg every cycle; 140mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-06
End date: 2010-10-06
Epirubicin
Dosage: 166mg every cycle; 140mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-27
Fluorouracil
Dosage: 830 mg every cycle; 700 mg, every cycle
Indication: Breast Cancer
Start date: 2010-10-06
Fluorouracil
Dosage: 830 mg every cycle; 700 mg, every cycle
Indication: Breast Cancer
Start date: 2010-10-27
Possible Epirubicin side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-20
Patient: 44 year old female, weighing 55.5 kg (122.1 pounds)
Reactions: Abdominal Pain, Intestinal Ischaemia, Colitis Ischaemic, White Blood Cell Count Decreased, Vomiting, Blood Creatine Phosphokinase Increased, Gastrointestinal Necrosis, Pyrexia, Multi-Organ Failure, Diarrhoea, GAS Gangrene, Heart Rate Increased, Bone Marrow Failure, Neutropenia, Clostridial Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 7 cycles, total 4 courses
Indication: Breast Cancer
Start date: 2011-07-22
End date: 2011-09-22
Epirubicin
Dosage: 7 cycles, total 4 courses
Indication: Breast Cancer
Start date: 2011-07-22
End date: 2011-09-22
Taxotere
Dosage: 4 cycles, total 3 courses, dose taken once daily
Indication: Breast Cancer
Start date: 2011-10-14
End date: 2011-11-25
Other drugs received by patient: Leucon; Lorazepam; Decadron Phosphate; Lorazepam; Kytril; Prochlorperazine; Kytril; Cepharanthin; Decadron Phosphate; Marzulene S
Possible Epirubicin side effects in
Reported by a health professional (non-physician/pharmacist) from Egypt on 2012-06-18
Patient:
Reactions: Vomiting
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: (500 mg/m2 (every three weeks) intravenous (not otherwise specified))
Indication: Breast Cancer Stage III
Epirubicin
Dosage: (100 mg/m2 (every three weeks) intravenous (not otherwise specified))
Indication: Breast Cancer Stage III
Fluorouracil
Dosage: (500 mg/m2 (every three weeks) intravenous bolus)
Indication: Breast Cancer Stage III
Possible Epirubicin side effects in
Reported by a health professional (non-physician/pharmacist) from Egypt on 2012-06-15
Patient:
Reactions: Vomiting
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: (500 mg/m2 (every three weeks) intravenous (not otherwise specified)
Indication: Inflammatory Carcinoma of Breast Stage III
Epirubicin
Dosage: (100 mg/m2 (every three weeks) intravenous (not otherwise specified)
Indication: Inflammatory Carcinoma of Breast Stage III
Fluorouracil
Dosage: (500 mg/m2 (every three weeks) intravenous bolus)
Indication: Inflammatory Carcinoma of Breast Stage III
Possible Epirubicin side effects in female
Reported by a individual with unspecified qualification from Germany on 2012-06-07
Patient: female
Reactions: Vomiting, Nausea, Inappropriate Antidiuretic Hormone Secretion, Coma
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Start date: 2012-04-16
End date: 2012-04-16
Epirubicin
Indication: Breast Cancer
Start date: 2012-04-16
End date: 2012-04-16
Other drugs received by patient: Prednisone TAB; Dexamethasone; Sodium Chloride; Aprepitant; Mesna; Granisetron; Hydroxychloroquine Sulfate
Possible Epirubicin side effects in female
Reported by a physician from Germany on 2012-05-18
Patient: female, weighing 110.0 kg (242.0 pounds)
Reactions: Vomiting, Nasopharyngitis, Nausea, Diarrhoea, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000 mg, unk
Start date: 2010-11-05
End date: 2011-01-07
Epirubicin
Dosage: 200 mg, unk
Start date: 2010-11-05
End date: 2011-01-07
Fluorouracil
Dosage: 100 mg, unk
Start date: 2010-11-05
End date: 2011-01-07
NO Treatment Received
Dosage: no treatment
Indication: Breast Cancer
Other drugs received by patient: Paracodin Bitartrate TAB; Cefuroxime; Acetylcysteine; Allopurinol
Possible Epirubicin side effects in 38 year old female
Reported by a individual with unspecified qualification from United States on 2012-01-27
Patient: 38 year old female
Reactions: Confusional State, Vomiting, Gastrointestinal Toxicity, Neurological Decompensation, Nausea, Oesophageal Fistula, FAT Embolism, Pyrexia, Haematemesis, Grand MAL Convulsion, Cerebral Artery Embolism, Brain Oedema, Intracranial Pressure Increased, Heart Injury, Gastrointestinal Injury
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Indication: Oesophageal Carcinoma
Epirubicin
Indication: Oesophageal Carcinoma
Fluorouracil
Indication: Oesophageal Carcinoma
Oxaliplatin
Indication: Oesophageal Carcinoma
Possible Epirubicin side effects in female
Reported by a physician from Switzerland on 2011-11-28
Patient: female, weighing 63.0 kg (138.6 pounds)
Reactions: Vomiting, Nausea, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: 75mgm2 per day
Indication: Neoplasm
Start date: 2009-04-01
End date: 2009-04-06
Pazopanib
Dosage: 800mg per day
Administration route: Oral
Indication: Neoplasm
Start date: 2009-03-30
End date: 2009-04-05
Other drugs received by patient: Laxoberon; Emend; Folic Acid; Omeprazole; Acetaminophen
Possible Epirubicin side effects in 38 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-25
Patient: 38 year old female
Reactions: Confusional State, Fistula, Vomiting, Nausea, Neurological Decompensation, Gastrointestinal Toxicity, Pyrexia, Grand MAL Convulsion, AIR Embolism, Brain Oedema, Intracranial Pressure Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Cisplatin
Dosage: two cycles given, consolidation therapy
Epirubicin
Epirubicin
Fluorouracil
Dosage: continuous infusion
Fluorouracil
Dosage: continuous infusion
Fluorouracil
Dosage: two cycles given, consolidation therapy
Oxaliplatin
Dosage: 2-hour duration
Oxaliplatin
Dosage: 2-hour duration
Therapeutic Radiopharmaceuticals
Dosage: 50 gy given in 28 fraction
|
